MILWAUKEE, Wis., Oct. 30, 2025 (GLOBE NEWSWIRE) — Koss Corporation (NASDAQ: KOSS) (the “Company”), the U.S. based high-fidelity headphone company, has reported its results for the first quarter ended September 30, 2025. For the three months ended September 30, 2025, net sales of $4,070,778 were $868,910, or 27.1%, higher compared to $3,201,868 for the same … Read more
Jamison Hensley Close Jamison Hensley ESPN Staff Writer Jamison Hensley is a reporter covering the Baltimore Ravens for ESPN. Jamison joined ESPN in 2011, covering the AFC North before focusing exclusively on the Ravens beginning in 2013. Jamison won the National Sports Media Association Maryland Sportswriter of the Year award in 2018, and he authored … Read more
BEIJING, Oct. 30, 2025 (GLOBE NEWSWIRE) — InnoCare Pharma (HKEX: 09969; SSE: 688428), a leading biopharmaceutical company focusing on the treatment of cancer and autoimmune diseases, announced today that the first patient has been dosed in the clinical trial of its novel B7-H3 targeted ADC, ICP-B794, in China. ICP-B794 is a novel ADC comprising a … Read more
Businessman working on laptop with PRIVATE EQUITY inscription, new business concept getty While other private equity investors scrutinize spreadsheets, Sam Thompson at Progress Partners identifies behavioral patterns predicting startup failure with measured accuracy. His due-diligence process reveals founder capacity through their reactions to pressure. “It’s human factors that really are the deciding factor between success … Read more
Las Vegas, Oct. 30, 2025 (GLOBE NEWSWIRE) — New York – October 29, 2025 – Allied Gaming & Entertainment Inc. (NASDAQ: AGAE) (“Allied” or the “Company”), a global experiential entertainment company, celebrates two major events—one recently hosted and one upcoming—at its flagship property, Allied Esports’ HyperX Arena Las Vegas, underscoring the Company’s continued leadership in … Read more
MONTREAL, Oct. 30, 2025 (GLOBE NEWSWIRE) — Knight Therapeutics Inc. (TSX: GUD) (“Knight”), a pan-American (ex-USA) specialty pharmaceutical company, announced today the launch of JORNAY PM™ (methylphenidate HCI extended-release capsules) in Canada. JORNAY PM™ is an extended-release formulation of methylphenidate, a stimulant medication for the treatment of Attention-Deficit Hyperactivity Disorder (ADHD) in children 6-12 years … Read more
DALLAS, Oct. 30, 2025 (GLOBE NEWSWIRE) — Beneficient (NASDAQ: BENF) (the “Company”), a technology-enabled platform providing exit opportunities and primary capital solutions and related trust and custody services to holders of alternative assets through its proprietary online platform AltAccess, today announced that, by letter dated October 29, 2025, the Company was notified by The Nasdaq … Read more
Oct 30, 2025, 06:18 PM ET SAN FRANCISCO — Tony Vitello fully recognizes he is an unconventional call-up to Major League Baseball, making the leap from the college coaching ranks at Tennessee to the San Francisco Giants while bypassing the minor leagues. Yet, Vitello hardly seems fazed by the pressures of taking such a daunting … Read more
SOUTH SAN FRANCISCO, Calif., Oct. 30, 2025 (GLOBE NEWSWIRE) — BridgeBio Oncology Therapeutics, Inc. (“BBOT”) (Nasdaq: BBOT), a clinical-stage biopharmaceutical company focused on RAS-pathway malignancies, today announced two poster presentations featuring BBO-10203, a first-in-class, orally bioavailable, selective breaker of the RAS:PI3Kα interaction, at the San Antonio Breast Cancer Symposium (SABCS) being held December 9-12, 2025, … Read more
SALT LAKE CITY, UT – OCTOBER 29: Jrue Holiday #5 of the Portland Trail Blazers rushes the ball up the court during the first half of their game against the Utah Jazz at the Delta Center on October 29, 2025 in Salt Lake City, Utah. NOTE TO USER: User expressly acknowledges and agrees that, by … Read more